Oxolife is pioneering a biotech initiative to enhance live birth outcomes by focusing on a critical yet unaddressed aspect of fertility treatments: embryo implantation. Their novel drug, OXO 001, represents a significant advancement in fertility medicine, offering hope to millions of women struggling with fertility issues.

Basic information

Country

SPAIN

Group Name

Oxolife

Source

Source